| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Arteaga E et al. | In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women. | 1998 | Menopause | pmid:9689190 |
| Kalay AE et al. | Efficacy of citalopram on climacteric symptoms. | 2007 Mar-Apr | Menopause | pmid:17224858 |
| Rubinacci A et al. | Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women. | 2003 May-Jun | Menopause | pmid:12792297 |
| Ventura P et al. | Continuous combined hormone replacement therapy with oral 17beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women. | 2001 Jul-Aug | Menopause | pmid:11449082 |
| Naessen T et al. | Early postmenopausal hormone therapy improves postural balance. | 2007 Jan-Feb | Menopause | pmid:17091024 |
| Krämer EA et al. | The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells. | 2005 Jul-Aug | Menopause | pmid:16037763 |
| Battaglia C et al. | Angeliq versus Activelle in normotensive postmenopausal women: a prospective, randomized pilot study. | 2009 Jul-Aug | Menopause | pmid:19194341 |
| Al-Azzawi F et al. | Bone mineral density in postmenopausal women treated with a vaginal ring delivering systemic doses of estradiol acetate. | 2005 May-Jun | Menopause | pmid:15879923 |
| Shakir YA et al. | Combined hormone therapy in postmenopausal women with features of metabolic syndrome. Results from a population-based study of Swedish women: Women's Health in the Lund Area study. | 2004 Sep-Oct | Menopause | pmid:15356408 |
| Speroff L et al. | The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt) on the frequency and intensity of vasomotor symptoms. | 2000 Nov-Dec | Menopause | pmid:11127760 |
| Birge SJ | Nonvertebral "osteoporotic" fractures: a brain disease or bone disease? | 2007 Jan-Feb | Menopause | pmid:17179791 |
| Soares CN et al. | Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. | 2006 Sep-Oct | Menopause | pmid:16894334 |
| Pedersen SH et al. | Progestins oppose the effects of estradiol on the endothelin-1 receptor type B in coronary arteries from ovariectomized hyperlipidemic rabbits. | 2008 May-Jun | Menopause | pmid:18188139 |
| Cagnacci A et al. | Transdermal administration of estradiol and norethisterone: effect on the uterus and uterine arteries. | 2000 Mar-Apr | Menopause | pmid:10746894 |
| Wasnich RD et al. | Changes in bone density and turnover after alendronate or estrogen withdrawal. | 2004 Nov-Dec | Menopause | pmid:15545790 |
| Greenwald MW et al. | Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects. | 2005 Nov-Dec | Menopause | pmid:16278618 |
| Hofling M et al. | Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women. | 2007 Mar-Apr | Menopause | pmid:17108847 |
| Christodoulakos GE et al. | The effect of hormone therapy and raloxifene on serum matrix metalloproteinase-2 and -9 in postmenopausal women. | 2004 May-Jun | Menopause | pmid:15167309 |
| Johnson JV et al. | Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy. | 2002 Jan-Feb | Menopause | pmid:11791082 |
| Niskanen L et al. | Does postmenopausal hormone replacement therapy affect cardiac autonomic regulation in osteoporotic women? | 2002 Jan-Feb | Menopause | pmid:11791086 |
| Price T | Progesterone receptor membrane component 1: is metabolism integral to its function and what other steroids are involved? | 2013 | Menopause | pmid:23511707 |
| Rachoń D et al. | Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women. | 2006 Sep-Oct | Menopause | pmid:16894332 |
| Stanczyk FZ and Winer SA | Effect of hormone therapy on breast epithelial cell proliferation. | 2013 | Menopause | pmid:23615638 |
| Cheng G et al. | Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women. | 2013 | Menopause | pmid:23615640 |
| Neubauer H et al. | Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy. | 2013 | Menopause | pmid:23615641 |
| Mueck AO et al. | Medroxyprogesterone acetate versus norethisterone: effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures. | 2002 Jul-Aug | Menopause | pmid:12082363 |
| Botteman MF et al. | A cost-effectiveness evaluation of two continuous-combined hormone therapies for the management of moderate-to-severe vasomotor symptoms. | 2004 May-Jun | Menopause | pmid:15167315 |
| Mitwally MF et al. | Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome. | 2002 Jul-Aug | Menopause | pmid:12082359 |
| Raudaskoski T et al. | Plasma insulin-like growth factor-I and its binding proteins 1 and 3 during continuous nonoral and oral combined hormone replacement therapy. | 1998 | Menopause | pmid:9872487 |
| Davis SR et al. | Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study. | 2008 Nov-Dec | Menopause | pmid:18806686 |
| Zegura B et al. | The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. | 2006 Jul-Aug | Menopause | pmid:16837886 |
| Vitale C et al. | Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy. | 2005 Sep-Oct | Menopause | pmid:16145309 |
| Rinaldi M et al. | Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis. | 2005 Sep-Oct | Menopause | pmid:16145317 |
| Beck P et al. | Effect of contraceptive steroids on arginine- stimulated glucagon and insulin secretion in women. II. Carbohydrate and lipid physiology in insulin-dependent diabetics. | 1976 | Metab. Clin. Exp. | pmid:1246206 |
| PAULSEN CA | PROGESTIN METABOLISM: SPECIAL REFERENCE TO ESTROGENIC PATHWAYS. | 1965 | Metab. Clin. Exp. | pmid:14261416 |
| Johansen JS et al. | Time-dependent variations in bone turnover parameters during 2 months' cyclic treatment with different doses of combined estrogen and progestogen in postmenopausal women. | 1990 | Metab. Clin. Exp. | pmid:2233271 |
| Hassager C et al. | Collagen synthesis in postmenopausal women during therapy with anabolic steroid or female sex hormones. | 1990 | Metab. Clin. Exp. | pmid:2233278 |
| Leklem JE et al. | Effect of oral contraceptives on urinary metabolite excretions after administration of L-tryptophan or L-kynurenine sulfate. | 1973 | Metab. Clin. Exp. | pmid:4587003 |
| Wynne TP et al. | Effect of a controlled exercise program on serum lipoprotein levels in women on oral contraceptives. | 1980 | Metab. Clin. Exp. | pmid:7453571 |
| Kekki M and Nikkilä EA | Plasma triglyceride turnover during use of oral contraceptives. | 1971 | Metab. Clin. Exp. | pmid:4105291 |
| Ence TJ et al. | Heparin metabolism and heparin-release lipase activity during long-term estrogen-progestin treatment. | 1976 | Metab. Clin. Exp. | pmid:1250155 |
| Davidson MB | Letter: The effect of contraceptive steroids on carbohydrate metabolism. | 1974 | Metab. Clin. Exp. | pmid:4834911 |
| Spencer CP et al. | Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women. | 2000 | Metab. Clin. Exp. | pmid:10877199 |
| Beck P et al. | Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women: I-Lipid physiology. | 1975 | Metab. Clin. Exp. | pmid:1152675 |
| Rose DP and Toseland PA | Urinary excretion of quinolinic acid and other tryptophan metabolites after deoxypyridoxine or oral contraceptive administration. | 1973 | Metab. Clin. Exp. | pmid:4683526 |
| STEINER GJ et al. | HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS. | 1963 | Metab. Clin. Exp. | pmid:14261422 |
| HOUGIE C et al. | EFFECT OF A PROGESTIN-ESTROGEN ORAL CONTRACEPTIVE ON BLOOD CLOTTING FACTORS. | 1965 | Metab. Clin. Exp. | pmid:14261425 |
| RICE WRAY E et al. | THE ACCEPTABILITY OF ORAL PROGESTINS IN FERTILITY CONTROL. | 1965 | Metab. Clin. Exp. | pmid:14261432 |
| Levine LS et al. | Androgen production in boys with sexual precocity and congenital adrenal hyperplasia. | 1972 | Metab. Clin. Exp. | pmid:4335735 |
| Heller J and Himmelstein KJ | Poly(ortho ester) biodegradable polymer systems. | 1985 | Meth. Enzymol. | pmid:3930918 |
| Cowsar DR et al. | Poly(lactide-co-glycolide) microcapsules for controlled release of steroids. | 1985 | Meth. Enzymol. | pmid:4046844 |
| Kraut R et al. | Fluorescence correlation methods for imaging cellular behavior of sphingolipid-interacting probes. | 2012 | Methods Cell Biol. | pmid:22325612 |
| Maiti BR and Sahu A | Effects of a long-term treatment with norethisterone (a progestogen-only contraceptive) on the epidermis, the sebaceous glands, the meibomian gland and the Harderian gland in the cycling female rat. | 1981 | Mikroskopie | pmid:7322374 |
| Maiti BR and Hikim AS | The effect of norethisterone (a progesterone-only contraceptive) on the endocrine pancreas of the albino rat. | 1976 | Mikroskopie | pmid:798129 |
| Maiti BR and Sahu A | Leucocytic responses to long-term treatment of norethisterone (a progestogen-only contraceptive) in the female rat. | 1981 | Mikroskopie | pmid:7197335 |
| De Patre P | [Use of an estro-progestational combination in the treatment of dysfunctional pre-climacteric meno-metrorrhagias]. | 1975 | Minerva Ginecol | pmid:778678 |
| Campagnoli C et al. | [Changes in serum transaminases induced by administration of estroprogestinics]. | 1970 | Minerva Ginecol | pmid:5446692 |
| Capra A et al. | [Use of an estroprogestinic association (norethindrone 2 mg and mestranol 100 gamma) in dysfunctional gynecologic syndromes]. | 1969 | Minerva Ginecol | pmid:5404341 |
| Tomassini A et al. | [An unusual case of hymenal endometriosis]. | 1978 | Minerva Ginecol | pmid:703978 |
| HAENDLER Y | [THE "HOPELESS CASES" IN FEMALE STERILITY]. | 1963 | Minerva Ginecol | pmid:14112412 |
| Moretti G et al. | [Transitory ischemic attacks, migraine and progestogen drugs. Etiopathogenetic correlations]. | 1980 | Minerva Med. | pmid:7432644 |
| Tyler ET | A new low-dose combination oral contraceptive. | 1969 | Minn Med | pmid:5354091 |
| JUNKMANN K | [HORMONAL CONTRACEPTION]. | 1964 | Mitt Dtsch Pharm Ges Pharm Ges DDR | pmid:14247999 |
| Malviya G et al. | Synthesis and evaluation of 99mTc-labelled monoclonal antibody 1D09C3 for molecular imaging of major histocompatibility complex class II protein expression. | 2011 | Mol Imaging Biol | pmid:20812032 |
| Kitamura Y et al. | Neuroprotective effect of a new DJ-1-binding compound against neurodegeneration in Parkinson's disease and stroke model rats. | 2011 | Mol Neurodegener | pmid:21740546 |
| Dickey CA et al. | Pharmacologic reductions of total tau levels; implications for the role of microtubule dynamics in regulating tau expression. | 2006 | Mol Neurodegener | pmid:16930453 |
| Sieuwerts AM et al. | Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women. | 2011 | Mol Oncol | pmid:21956102 |
| Palagyi A et al. | Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents. | 2010 | Mol. Cancer | pmid:20509860 |
| Bolhassani A et al. | Improvement of different vaccine delivery systems for cancer therapy. | 2011 | Mol. Cancer | pmid:21211062 |
| Attardi BJ et al. | Relative progestational and androgenic activity of four progestins used for male hormonal contraception assessed in vitro in relation to their ability to suppress LH secretion in the castrate male rat. | 2010 | Mol. Cell. Endocrinol. | pmid:20599585 |
| Koubovec D et al. | Synthetic progestins used in HRT have different glucocorticoid agonist properties. | 2005 | Mol. Cell. Endocrinol. | pmid:16125839 |
| Gao J et al. | Ligand-activated progesterone receptor isoform hPR-A is a stronger transactivator than hPR-B for the expression of IGFBP-1 (insulin-like growth factor binding protein-1) in human endometrial stromal cells. | 2000 | Mol. Endocrinol. | pmid:11117526 |
| Jeng MH and Jordan VC | Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells. | 1991 | Mol. Endocrinol. | pmid:1834933 |
| Kohnen G et al. | Endothelin receptor expression in human decidua. | 1998 | Mol. Hum. Reprod. | pmid:9542978 |
| Hampton AL et al. | Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects. | 1999 | Mol. Hum. Reprod. | pmid:10321809 |
| Manoharan C et al. | The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activity. | 2006 Nov-Dec | Mol. Membr. Biol. | pmid:17127621 |
| Hodder AN et al. | Analysis of structure and function of the giant protein Pf332 in Plasmodium falciparum. | 2009 | Mol. Microbiol. | pmid:19007413 |
| Castro I et al. | Molecular mechanisms of the antihormonal and antiimplantation effects of norethisterone and its A-ring reduced metabolites. | 1995 | Mol. Reprod. Dev. | pmid:7766408 |
| Yao K et al. | Electromagnetic noise inhibits radiofrequency radiation-induced DNA damage and reactive oxygen species increase in human lens epithelial cells. | 2008 | Mol. Vis. | pmid:18509546 |
| Liu X et al. | Probing Steroidal Substrate Specificity of Cytochrome P450 BM3 Variants. | 2016 | Molecules | pmid:27294908 |
| Litzke F et al. | [Use of norethisterone acetate for the control of reproduction in cattle]. | 1971 | Monatsh Veterinarmed | pmid:5170110 |
| Szarvas Z | [Peculiar secretory activity of endometrial cancer cells during progestational therapy]. | 1978 | Morphol Igazsagugyi Orv Sz | pmid:714043 |
| Notter G and Wicklund H | [Treatment of inoperable and metastasizing breast cacinoma with gestagen hormones]. | 1967 | Munch Med Wochenschr | pmid:5632005 |
| Shyama SK et al. | Genotoxic effect of Anovlar 21, an oral contraceptive, on mouse bone marrow. | 1991 | Mutat. Res. | pmid:2027340 |
| Murthy PB and Prema K | Further studies on sister-chromatid exchange frequency in users of hormonal contraceptives. | 1983 | Mutat. Res. | pmid:6402698 |
| Röhrborn G and Hansmann I | Oral contraceptives and chromosome segregation in oocytes of mice. | 1974 | Mutat. Res. | pmid:4431427 |
| Ahmad ME et al. | Evaluation of genotoxic potential of synthetic progestins-norethindrone and norgestrel in human lymphocytes in vitro. | 2001 | Mutat. Res. | pmid:11423341 |
| Martelli A et al. | Species, sex and inter-individual differences in DNA repair induced by nine sex steroids in primary cultures of rat and human hepatocytes. | 2003 | Mutat. Res. | pmid:12694747 |
| Shyama SK and Abdul Rahiman M | Progestin (norethisterone)-induced genetic damage in mouse bone marrow. | 1993 | Mutat. Res. | pmid:7687021 |
| Dhillon VS and Dhillon IK | Genotoxicity evaluation of norethisterone acetate. | 1996 | Mutat. Res. | pmid:8596541 |
| Martelli A et al. | Induction of micronuclei and of enzyme-altered foci in the liver of female rats exposed to progesterone and three synthetic progestins. | 1998 | Mutat. Res. | pmid:9804880 |
| Badr FM and Badr RS | Studies on the mutagenic effect of contraceptive drugs. I. Induction of dominant lethal mutations in female mice. | 1974 | Mutat. Res. | pmid:4431426 |
| Kabarity A and Mazrooei S | Further investigations on the cytological effects of some contraceptives. | 1984 | Mutat. Res. | pmid:6708960 |
| FLOWERS CE | THE USE OF PROGESTINS IN OBSTETRICS AND GYNECOLOGY. | 1964 | N C Med J | pmid:14143212 |
| Cerin A et al. | Adverse endometrial effects of long-cycle estrogen and progestogen replacement therapy. The Scandinavian LongCycle Study Group. | 1996 | N. Engl. J. Med. | pmid:8592546 |
| Hirvonen E et al. | Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. | 1981 | N. Engl. J. Med. | pmid:7453723 |
| Heinonen OP et al. | Cardiovascular birth defects and antenatal exposure to female sex hormones. | 1977 | N. Engl. J. Med. | pmid:830309 |
| Braverman DZ et al. | Effects of pregnancy and contraceptive steroids on gallbladder function. | 1980 | N. Engl. J. Med. | pmid:7351927 |
| Jensen J et al. | Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. | 1985 | N. Engl. J. Med. | pmid:4047104 |
| Gregg WI | Galactorrhea after contraceptive hormones. | 1966 | N. Engl. J. Med. | pmid:5949006 |